Oral vaccination in man using antigens in particles: Current status

European Journal of Pharmaceutical Sciences

Volumn 14, Issue 3, 2001, Pages 183-189

  Brayden, David J ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

M cells; Oral vaccination; Peyer's patches; Targeting

Indexed keywords

ANTIBODIES; ANTIGENS; CELLS; IMMUNOLOGY;

ADJUVANTS;

VACCINES;

ADJUVANT; ANTIGEN; CHOLERA TOXIN; LATEX; LIPOSOME; MICROSPHERE; OVALBUMIN; PERTUSSIS TOXIN; POLYMER; POLYSTYRENE; STAPHYLOCOCCUS ENTEROTOXIN B; TETANUS TOXOID; VACCINE;

ARTICLE; DRUG DELIVERY SYSTEM; HUMAN; IMMUNE RESPONSE; MOUSE; NONHUMAN; PARTICULATE MATTER; PEYER PATCH; PRIORITY JOURNAL; VACCINATION;

EID: 0034822710     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(01)00175-0     Document Type: Note

References (36)

1. Novel oral drug delivery gateways for biotechnology products: polypeptides and vaccines
2. Lectin-bearing polymerised liposomes as potential oral vaccine carriers
3. Lectin-mediated mucosal delivery of drugs and nanoparticles
4. Differential surface characteristics of M cells from mouse intestinal Peyer's and caecal patches
5. Development of a single shot subunit vaccine for HIV-1. 5. Programmable in vivo autoboost and long lasting neutralizing neutralising response
6. Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biodegradable particles: effect of formulation and route of immunization on induction of Th1 and Th2 cells
7. Number, size and distribution of Peyer's patches in the human intestine. Part 1. The development of Peyer's patches
8. PLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systems
9. The design of vaccines against Helicobacter pylori and their development
10. Evaluation of nano- and microparticle uptake by the gastrointestinal tract
11. The mechanism of uptake of biodegradable microparticles in caco-2 cells is size-dependent
12. The oral absorption of microparticles: neither exceptional nor unusual
13. Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting
14. M cells in the Peyer's patches of the intestine
15. Human intestinal M cells display the sialyl Lewis A antigen
16. Transcutaneous immunisation: a human vaccine delivery system using a patch
17. Safety and immunogenicity of intranasally-administered inactivated trivalent virosome-formulated influenza vaccine containing Escherichia coli heat labile toxin as a mucosal adjuvant
18. Expression of specific markers and particle transport in a new human intestinal M cell model
19. Effectiveness of liposomes: processing surface-linked recombinant B subunit of cholera toxin as an oral antigen delivery system
20. Optimising oral vaccines: induction of systemic and mucosal B cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant
21. Comparison of poly(DL-lactide-co-glycolide) and polystyrene microsphere targeting to intestinal M cells
22. Towards clinical testing of a single-administration tetanus vaccine based on PLA/PLGA microspheres
23. Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria
24. Epithelial M cells: differentiation and function
25. Protection against vaginal SIV transmission with microencapsulated vaccine
26. Oral immunisation with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults
27. Binding and uptake of biodegradable poly-DL-lactide micro- and nanoparticles in intestinal epithelia
28. CpG DNA is an effective oral adjuvant to protein antigens in mice
29. Microparticles and polymers for the mucosal delivery of vaccines
30. Preclinical evaluation of microencapsulated CFA/II oral vaccine against entertoxigenic E. coli
31. Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine
32. Lectin-mediated transport of nanoparticles across Caco-2 and OK cells
33. Oral immunisation of rats with proteinoid microspheres encapsulating influenza virus antigens
34. Salmonella-induced M cell formation in germ-free mouse Peyer's patch tissue
35. Enteral immunisation and challenge of volunteers given enterotoxigenic E. coli CFA/II encapsulated in biodegradable microspheres
36. Protective effects of an oral microencapsulated Mycoplasma hyopneumoniae vaccine against experimental infection in pigs